Comparison of efficacy and toxicity between botulinum toxin subtypes A1 and A2 in cynomolgus macaques.

This study suggested that A2NTX products are more suitable for the treatment of neurological disorders.
PMID: 30193802 [PubMed - as supplied by publisher]

Source: Toxicon - September 4, 2018 Category: Toxicology Authors: Torii Y, Sasaki M, Shin MC, Akaike N, Kaji R Tags: Toxicon Source Type: research